U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT06856265) titled 'Efficacy of Mavacamten Combined With Radiofrequency Ablation in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy' on Feb. 26.
Brief Summary: This study aims to evaluate the efficacy and safety of Mavacamten combined with radiofrequency ablation compared to Mavacamten alone in patients with symptomatic obstructive hypertrophic cardiomyopathy (HOCM).
Participants were randomized into two groups:
Study Start Date: Feb. 26
Study Type: INTERVENTIONAL
Condition:
Obstructive Hypertrophic Cardiomyopathy
Mavacamten
Radiofrequency Ablation
Intervention:
PROCEDURE: radiofrequency ablation
Radiofrequency Ablation is a m...